Researcher profile

Katherine J. Lee

Katherine J. Lee contributes to research discovery and scholarly infrastructure.

ResearcherAffiliation not importedOpen to collaborate

Trust snapshot

Quick read

Trust 17 - UnverifiedVerification L1Unclaimed author
4works
0followers
2topics
4close collaborators

Actions

Decide how to stay connected

Follow researcher0

Identity and collaboration

How to connect with this researcher

Claiming links this public author record to a researcher profile and unlocks direct collaboration workflows.

Log in to claim

Direct collaboration

Open a focused conversation when the fit is right

Claim this author entity first to unlock direct invitations.

Research graph

See the researcher in context

Open full explorer

Inspect adjacent work, topics, institutions and collaborators without jumping out to a separate graph page.

Building this graph slice

BZPEER is loading the nearby papers, people, topics and institutions for this page.

Published work

4 published item(s)

preprint2023arXiv

Recoverability and estimation of causal effects under typical multivariable missingness mechanisms

In the context of missing data, the identifiability or "recoverability" of the average causal effect (ACE) depends on causal and missingness assumptions. The latter can be depicted by adding variable-specific missingness indicators to causal diagrams, creating "missingness-directed acyclic graphs" (m-DAGs). Previous research described ten canonical m-DAGs, representing typical multivariable missingness mechanisms in epidemiological studies, and determined the recoverability of the ACE in the absence of effect modification. We extend the research by determining the recoverability of the ACE in settings with effect modification and conducting a simulation study evaluating the performance of widely used missing data methods when estimating the ACE using correctly specified g-computation, which has not been previously studied. Methods assessed were complete case analysis (CCA) and various multiple imputation (MI) implementations regarding the degree of compatibility with the outcome model used in g-computation. Simulations were based on an example from the Victorian Adolescent Health Cohort Study (VAHCS), where interest was in estimating the ACE of adolescent cannabis use on mental health in young adulthood. In the canonical m-DAGs that excluded unmeasured common causes of missingness indicators, we derived the recoverable ACE if no incomplete variable causes its missingness, and non-recoverable otherwise. Besides, the simulation showed that compatible MI approaches may enable approximately unbiased ACE estimation, unless the outcome causes its missingness or it causes the missingness of a variable that causes its missingness. Researchers must consider sensitivity analysis methods incorporating external information in the latter setting. The VAHCS case study illustrates the practical implications of these findings.

preprint2022arXiv

A comparison of strategies for selecting auxiliary variables for multiple imputation

Multiple imputation (MI) is a popular method for handling missing data. Auxiliary variables can be added to the imputation model(s) to improve MI estimates. However, the choice of which auxiliary variables to include in the imputation model is not always straightforward. Including too few may lead to important information being discarded, but including too many can cause problems with convergence of the estimation procedures for imputation models. Several data-driven auxiliary variable selection strategies have been proposed. This paper uses a simulation study and a case study to provide a comprehensive comparison of the performance of eight auxiliary variable selection strategies, with the aim of providing practical advice to users of MI. A complete case analysis and an MI analysis with all auxiliary variables included in the imputation model (the full model) were also performed for comparison. Our simulation study results suggest that the full model outperforms all auxiliary variable selection strategies, providing further support for adopting an inclusive auxiliary variable strategy where possible. Auxiliary variable selection using the Least Absolute Selection and Shrinkage Operator (LASSO) was the best performing auxiliary variable selection strategy overall and is a promising alternative when the full model fails. All MI analysis strategies that we were able to apply to the case study led to similar estimates.

preprint2022arXiv

Making SMART decisions in prophylaxis and treatment studies

The optimal prophylaxis, and treatment if the prophylaxis fails, for a disease may be best evaluated using a sequential multiple assignment randomised trial (SMART). A SMART is a multi-stage study that randomises a participant to an initial treatment, observes some response to that treatment and then, depending on their observed response, randomises the same participant to an alternative treatment. Response adaptive randomisation may, in some settings, improve the trial participants' outcomes and expedite trial conclusions, compared to fixed randomisation. But 'myopic' response adaptive randomisation strategies, blind to multistage dynamics, may also result in suboptimal treatment assignments. We propose a 'dynamic' response adaptive randomisation strategy based on Q-learning, an approximate dynamic programming algorithm. Q-learning uses stage-wise statistical models and backward induction to incorporate late-stage 'payoffs' (i.e. clinical outcomes) into early-stage 'actions' (i.e. treatments). Our real-world example consists of a COVID-19 prophylaxis and treatment SMART with qualitatively different binary endpoints at each stage. Standard Q-learning does not work with such data because it cannot be used for sequences of binary endpoints. Sequences of qualitatively distinct endpoints may also require different weightings to ensure that the design guides participants to regimens with the highest utility. We describe how a simple decision-theoretic extension to Q-learning can be used to handle sequential binary endpoints with distinct utilities. Using simulation we show that, under a set of binary utilities, the 'dynamic' approach increases expected participant utility compared to the fixed approach, sometimes markedly, for all model parameters, whereas the 'myopic' approach can actually decrease utility.

preprint2022arXiv

Statistical analyses of ordinal outcomes in randomised controlled trials: protocol for a scoping review

Randomised controlled trials aim to assess the impact of one (or more) health interventions relative to other standard interventions. RCTs sometimes use an ordinal outcome, which is an endpoint that comprises of multiple, monotonically ordered categories that are not necessarily separated by a quantifiable distance. Ordinal outcomes are appealing in clinical settings as disease states can represent meaningful categories that may be of clinical importance. They can also retain information and increase statistical power compared to dichotomised outcomes. Target parameters for ordinal outcomes in RCTs may vary depending on the nature of the research question, the modelling assumptions, and the expertise of the data analyst. The aim of this scoping review is to systematically describe the use of ordinal outcomes in contemporary RCTs. Specifically, we aim to (i) identify which target parameters are of interest in trials that use an ordinal outcome; (ii) describe how ordinal outcomes are analysed in RCTs to estimate a treatment effect; and (iii) describe whether RCTs that use an ordinal outcome adequately report key methodological aspects specific to the analysis of the outcome. Results from this review will outline the current state of practice of the use of ordinal outcomes in RCTs. Ways to improve the analysis and reporting of ordinal outcomes in RCTs will be discussed. We will review RCTs that are published in the top four medical journals (BMJ, NEJM, The Lancet and JAMA) between 1 January 2012 and 31 July 2022 that use an ordinal outcome. The review will be conducted using PubMed. Our review will adhere to guidelines for scoping reviews as described in the PRISMA-ScR checklist. The study characteristics and design, including the target parameter(s) and statistical methods will be extracted from eligible studies. The data will be summarised using descriptive statistics.